Volumes and issues
-
Volume 84
-
Volume 83
-
Volume 82
-
Volume 81
-
Volume 80
-
Volume 79
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
-
Issue 1 supplement
l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic
- Issue 1
-
Volume 78
-
Volume 77
-
Volume 76
-
Volume 75
-
Volume 74
-
Volume 73
-
Volume 72
-
Volume 71
-
Volume 70
-
Volume 69
-
Volume 68
-
Volume 67
-
Volume 66
-
Volume 65
-
Volume 64
-
Volume 63
-
Volume 62
-
Volume 61
-
Volume 60
-
Volume 59
-
Volume 58
-
Volume 57
-
Volume 56
-
Volume 55
-
Volume 54
-
Volume 53
-
Volume 52
-
Volume 51
-
Volume 50
-
Volume 49
-
Volume 48
-
Volume 47
-
Volume 46
-
Volume 45
-
Volume 44
-
Volume 43
-
Volume 42
-
Volume 41
-
Volume 40
-
Volume 39
-
Volume 38
-
Volume 37
-
Volume 36
-
Volume 35
-
Volume 34
-
Volume 33
-
Volume 32
-
Volume 31
-
Volume 30
-
Volume 29
-
Volume 28
-
Volume 27
-
Volume 26
-
Volume 25
-
Volume 24
-
Volume 23
-
Volume 22
-
Volume 21
-
Volume 20
-
Volume 19
-
Volume 18
-
Volume 17
-
Volume 16
-
Volume 15
-
Volume 14
-
Volume 13
-
Volume 12
-
Volume 11
-
Volume 10
-
Volume 9
-
Volume 8
-
Volume 7
-
Volume 6
-
Volume 5
-
Volume 4
-
Volume 3
-
Volume 2
-
Volume 1